PREDICTIVE MARKERS FOR ADVERSE PREGNANCY OUTCOMES: INSIGHTS FROM A PROSPECTIVE COHORT STUDY ON MATERNAL FACTORS, BIOMARKERS, AND UTERINE ARTERY DOPPLER RESULTS

Authors

  • ANJU SURYAPANI Department of Obstetrics and Gynaecology, Rama Medical College, Hospital and Research Centre, Hapur, India
  • SHRUTI MOHAN UNIYAL Department of Obstetrics and Gynaecology, Rama Medical College, Hospital and Research Centre, Hapur, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i6.6010

Keywords:

Pregnancy complications, Predictive markers, Uterine artery doppler, Maternal biomarkers, Preterm birth, Pregnancy-induced hypertension, Intrauterine growth restriction

Abstract

Objective: Effective prediction tools are necessary for better outcomes when it comes to pregnancy-related complications such as intrauterine growth restriction (IUGR), pregnancy-induced hypertension (PIH), and premature birth. In order to improve early risk diagnosis and treatment, this study investigates relationships between maternal variables, first-trimester biomarkers, and second-trimester uterine artery Doppler findings.

Methods: Correlations between demographic characteristics, maternal dual test indicators (serum beta-HCG, serum PAPPA), and uterine artery Doppler tests were examined in a prospective cohort study including 500 pregnant women. Statistical studies evaluated correlations with IUGR, PIH, and premature birth.

Results: Serum beta-HCG levels below the 5th percentile correlated significantly with preterm birth (RR 2.3131, p = 0.0288). Low serum PAPP-A levels (<5th percentile) associated with PIH (RR 2.1447, p = 0.0204) and IUGR (RR 2.0953, p = 0.0002). Uterine artery Doppler indices (>0.58 RI) demonstrated associations with PIH (RR 2.2448) and IUGR (RR 1.6293).

Diastolic notching correlated with preterm birth, PIH, and IUGR.

Conclusion: The potential of serum beta-HCG, PAPP-A, and uterine artery Doppler indices as useful predictors of unfavorable pregnancy outcomes is highlighted by this study, which also highlights their use in early risk detection.

Downloads

Download data is not yet available.

References

American College of Obstetricians and Gynecologists. Pregnancy Complications; 2020. Available from: https://www.acog.org/womens-health/faqs/pregnancy/pregnancy-complications.

Hod M, Hadar E, Cabero Roura L. Prevention of type 2 diabetes among women with prior gestational diabetes mellitus. Int J Gynecol Obstet. 2015;131(S1) Suppl 3:S173-211. doi: 10.1016/j.ijgo.2015.02.010.

Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H. The International Federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first trimester screening and prevention. Int J Gynecol Obstet. 2019;145 Suppl 1:1-33. doi: 10.1002/ijgo.12802.

D Antonio F, Odibo AO, Prefumo F, Khalil A, Papageorghiou A, Bhide A. Counseling in fetal medicine: a practical guide. Cambridge University Press; 2019.

Vitale SG, Padula F, Gulino FA. Management of uterine fibroids in pregnancy: recent trends. Curr Opin Obstet Gynecol. 2015;27(6):432-7. doi: 10.1097/GCO.0000000000000220, PMID 26485457.

Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287-93.e1. doi: 10.1016/j.ajog.2017.11.561, PMID 29138036.

American College of Obstetricians and Gynecologists. Multifetal gestations: twin triplet and higher order multifetal pregnancies. Obstetrics and Gynecology. 2017;129(3):e70-88.

Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402-14. doi: 10.1097/AOG.0b013e3181e9322a, PMID 20664402.

Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D. Aspirin for evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017;217(6):685.e1-5. doi: 10.1016/j.ajog.2017.08.110, PMID 28888591.

Conde Agudelo A, Romero R, Kusanovic JP, Hassan SS, Yeo L, Erez O. Transient elastography of the cervix and prediction of spontaneous preterm birth. J Matern Fetal Neonatal Med. 2011;24(11):1347-65.

Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(2):110-120.e6. doi: 10.1016/j.ajog.2016.09.076, PMID 27640943.

Palatnik A, Grobman WA, Miller ES. Maternal age and severe maternal morbidity: A population-based retrospective cohort analysis. Arch Gynecol Obstet. 2020;301(5):1241-7.

Campbell S, Black RS, Lees CC, Silver RM, Dudenhausen J, Kingdom J. The hidden mortality of preterm birth: a global systematic review and meta-analysis. Am J Public Health. 2005;95(2):96-103.

Published

15-11-2024

How to Cite

SURYAPANI, A., and S. M. UNIYAL. “PREDICTIVE MARKERS FOR ADVERSE PREGNANCY OUTCOMES: INSIGHTS FROM A PROSPECTIVE COHORT STUDY ON MATERNAL FACTORS, BIOMARKERS, AND UTERINE ARTERY DOPPLER RESULTS”. International Journal of Current Pharmaceutical Research, vol. 16, no. 6, Nov. 2024, pp. 33-35, doi:10.22159/ijcpr.2024v16i6.6010.

Issue

Section

Original Article(s)